Nuo Therapeutics Inc., of Gaithersburg, Md., cited "prevailing market conditions" in deciding to withdraw its registration for a public offering on Nasdaq. The company had filed to sell 2.1 million shares at a price of between $4.50 and $5.50 per share after executing a 1-for-2.5 reverse stock split. Prior to changing its name in 2014, the company was known as Cytomedix Inc.